Deep Brain Stimulators (DBS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Deep Brain Stimulators (DBS) Pipeline Market Report Overview
Deep brain stimulators (DBS) comprise a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically implanted electrodes to specific targets in the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders.
The DBS pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The United States
· Europe · China · India · United Kingdom |
| Key Segment | · Non-Rechargeable Deep Brain Stimulators
· Rechargeable Deep Brain Stimulators |
| Key Regulatory Paths | · 510(k)
· PMA · CE · UKCA · TGA |
| Leading Companies | · Abbott Laboratories
· Adaptive Neuromodulation GmbH · Adept Neuro SA · Aleva Neurotherapeutics SA · Allegheny Health Network |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
DBS Pipeline Market Segments
A few of the key segments in the DBS pipeline market are non-rechargeable deep brain stimulators and rechargeable deep brain stimulators. As of August 2024, non-rechargeable deep brain stimulators have a higher number of pipeline products.
DBS Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segments Insights into the DBS Pipeline Market
DBS Pipeline Market Segmentation by Territories
A few of the key territories with the DBS pipeline market are Europe, the United States, India, China, and the United Kingdom among others. As of August 2024, the US had the highest number of DBS pipeline products.
DBS Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the DBS Pipeline Market
DBS Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the DBS pipeline products market are 510(k), CE, PMA, TGA, and UKCA among others. As of August 2024, PMA was the most followed pathway for pipeline products in the DBS market.
DBS Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the DBS Pipeline Market
DBS Pipeline Market – Competitive Landscape
A few of the key companies associated with the DBS pipeline market are Abbott Laboratories, Adaptive Neuromodulation GmbH, Adept Neuro SA, Aleva Neurotherapeutics SA, and Allegheny Health Network among others.
Abbott Laboratories: Abbott discovers, develops, manufactures, and sells a diverse range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices. The company also offers mineral nutrition products and dietary supplements. It has research and development facilities in the US, Colombia, India, Singapore, Spain, and the UK and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.
DBS Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the DBS Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
DBS Pipeline Market Segments Outlook (2024)
- Non-Rechargeable Deep Brain Stimulators
- Rechargeable Deep Brain Stimulators
DBS Pipeline Market Territories Outlook (2024)
- Europe
- The United States
- India
- China
- United Kingdom
DBS Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- PMA
- CE
- UKCA
- TGA
Scope
This report provides:
- Extensive coverage of the DBS devices under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of DBS and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of DBS under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Adaptive Neuromodulation GmbH
Adept Neuro SA
Aleva Neurotherapeutics SA
Allegheny Health Network
Amber Therapeutics Ltd
Baylor College of Medicine
Boston Scientific Corp
Clinatec
Deep Brain Innovations, LLC
Deep Brain Stimulation Technologies Pty Ltd
Enspire DBS Therapy Inc
Hangzhou General Stim Biotechnology Co Ltd
Hangzhou Promise Medical Technology Co Ltd
Louisiana State University
Massachusetts General Hospital
Medtronic Plc
National Cheng-Kung University Hospital
NeuroOne Medical Technologies Corp
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nexeon MedSystems Inc
Nia Therapeutics Inc
Oxford University Innovation Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stanford University
Sunnybrook Health Sciences Centre
UConn School of Medicine
University of California Los Angeles
University of California San Francisco
University of Central Florida
University of Florida
University of Illinois
University of Milan
University of Minnesota
University of Oxford
University of Pittsburgh
University of Rochester
University of South Florida
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the DBS pipeline market as of August 2024?
As of August 2024, the US had the highest number of DBS pipeline products.
-
Which was the most followed regulatory pathway in the DBS pipeline market as of August 2024?
As of August 2024, PMA was the most followed pathway for pipeline products in the DBS market.
-
Which are the major companies operating in the DBS pipeline market?
A few of the key companies associated with the DBS pipeline market are Abbott Laboratories, Adaptive Neuromodulation GmbH, Adept Neuro SA, Aleva Neurotherapeutics SA, and Allegheny Health Network among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Deep Brain Stimulators (DBS) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Deep Brain Stimulators (DBS) reports
